Literature DB >> 7586089

Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens.

G Jürgens1, A Fell, G Ledinski, Q Chen, F Paltauf.   

Abstract

Low density lipoprotein (LDL) isolated from human serum of different donors was enriched with plasmalogens and their diacyl analogs in order to investigate a possible effect of these phospholipids on the rate of lipid peroxidation in this lipoprotein. LDL was incubated with either vesicles of choline plasmalogen or phosphatidylcholine in presence of lipoprotein- deficient serum, or with liposomes of ethanolamine plasmalogen or phosphatidylethanolamine together with the non-specific phospholipid transfer protein isolated from beef liver. After re-isolation of LDL by ultracentrifugation, a dose-dependent incorporation of the exogenous phospholipids was obtained. Enrichment of LDL with choline plasmalogen resulted in a delay of the copper-catalyzed oxidation of LDL from five different donors. LDL from two donors was also enriched with diacylglycerophosphocholine which led to a delay of oxidation, but the protective effect was smaller than with choline plasmalogen. Enrichment of LDL from two additional donors with ethanolamine plasmalogen resulted in the strongest protection against oxidation, whereas, diacylglycerophospho-ethanolamine had little effect. The delay of the copper-catalyzed LDL oxidation may be due to a direct antioxidative action of the plasmalogens, which are partially degraded during the lag phase of oxidation, or to an indirect effect caused by alteration of the LDL surface in the presence of an excess of glycerophospholipids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586089     DOI: 10.1016/0009-3084(95)02451-n

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  15 in total

1.  Synthesis and antioxidant properties of an unnatural plasmalogen analogue bearing a trans O-vinyl ether linkage.

Authors:  Ravi S Lankalapalli; Joseph T Eckelkamp; Debajit Sircar; David A Ford; Papasani V Subbaiah; Robert Bittman
Journal:  Org Lett       Date:  2009-07-02       Impact factor: 6.005

Review 2.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

3.  Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids in vitro.

Authors:  D Reiss; K Beyer; B Engelmann
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Chronic dietary n-3 polyunsaturated fatty acids deficiency affects the fatty acid composition of plasmenylethanolamine and phosphatidylethanolamine differently in rat frontal cortex, striatum, and cerebellum.

Authors:  S Favrelière; L Barrier; G Durand; S Chalon; C Tallineau
Journal:  Lipids       Date:  1998-04       Impact factor: 1.880

5.  Plasmalogens as endogenous antioxidants: somatic cell mutants reveal the importance of the vinyl ether.

Authors:  R A Zoeller; A C Lake; N Nagan; D P Gaposchkin; M A Legner; W Lieberthal
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

6.  Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids.

Authors:  D Hahnel; T Huber; V Kurze; K Beyer; B Engelmann
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

Review 7.  Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.

Authors:  Peter J Meikle; Scott A Summers
Journal:  Nat Rev Endocrinol       Date:  2016-10-21       Impact factor: 43.330

8.  Increased lipid peroxidation in LDL from type-2 diabetic patients.

Authors:  Romain Colas; Valérie Pruneta-Deloche; Michel Guichardant; Céline Luquain-Costaz; Christine Cugnet-Anceau; Myriam Moret; Hubert Vidal; Philippe Moulin; Michel Lagarde; Catherine Calzada
Journal:  Lipids       Date:  2010-08-12       Impact factor: 1.880

9.  Oxidative environment causes molecular remodeling in embryonic heart-a metabolomic and lipidomic fingerprinting analysis.

Authors:  Shairam Manickaraj; Deepak Thirumalai; Prashanth Manjunath; Viswanathan Sekarbabu; Sivasubramanian Jeganathan; Lakshmikirupa Sundaresan; Rajalakshmi Subramaniyam; Manivannan Jeganathan
Journal:  Environ Sci Pollut Res Int       Date:  2017-09-02       Impact factor: 4.223

10.  Ingestion of plasmalogen markedly increased plasmalogen levels of blood plasma in rats.

Authors:  Megumi Nishimukai; Takuya Wakisaka; Hiroshi Hara
Journal:  Lipids       Date:  2003-12       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.